In antitumor progression, berberine can induce tumor cell apoptosis by activating PI3K-AKT and MAPK-p53 signaling pathways or promoting the expression of FoxO1 and FoxO3, and upregulating pro-apoptotic proteins such as Bax and Bim. The gene discussed is AKT1; the disease is neoplasm.